Colgate-Palmolive (NYSE:CL) Shares Purchased by Vanguard Personalized Indexing Management LLC

Vanguard Personalized Indexing Management LLC grew its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 40.8% during the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 48,106 shares of the company’s stock after purchasing an additional 13,930 shares during the period. Vanguard Personalized Indexing Management LLC’s holdings in Colgate-Palmolive were worth $3,834,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also modified their holdings of CL. Morgan Stanley grew its stake in shares of Colgate-Palmolive by 3.2% in the third quarter. Morgan Stanley now owns 16,815,987 shares of the company’s stock worth $1,195,785,000 after acquiring an additional 514,559 shares in the last quarter. Northern Trust Corp grew its stake in Colgate-Palmolive by 3.3% during the 3rd quarter. Northern Trust Corp now owns 9,452,931 shares of the company’s stock worth $672,198,000 after purchasing an additional 305,862 shares in the last quarter. American Century Companies Inc. increased its holdings in Colgate-Palmolive by 2.0% during the 3rd quarter. American Century Companies Inc. now owns 6,590,405 shares of the company’s stock worth $468,644,000 after purchasing an additional 127,805 shares during the period. FMR LLC raised its position in Colgate-Palmolive by 27.3% in the 3rd quarter. FMR LLC now owns 5,597,742 shares of the company’s stock valued at $398,055,000 after purchasing an additional 1,199,660 shares in the last quarter. Finally, Nordea Investment Management AB boosted its stake in shares of Colgate-Palmolive by 10.1% in the 3rd quarter. Nordea Investment Management AB now owns 5,455,384 shares of the company’s stock valued at $390,005,000 after buying an additional 500,916 shares during the period. 80.41% of the stock is currently owned by hedge funds and other institutional investors.

Colgate-Palmolive Stock Performance

NYSE:CL traded down $0.01 during trading hours on Wednesday, reaching $94.56. 2,536,128 shares of the company’s stock were exchanged, compared to its average volume of 4,629,638. The company has a quick ratio of 0.70, a current ratio of 1.06 and a debt-to-equity ratio of 13.21. The firm has a market capitalization of $77.58 billion, a price-to-earnings ratio of 29.96, a P/E/G ratio of 3.48 and a beta of 0.40. Colgate-Palmolive has a 1-year low of $67.62 and a 1-year high of $95.59. The company has a 50-day moving average of $89.41 and a 200 day moving average of $83.40.

Colgate-Palmolive (NYSE:CLGet Free Report) last announced its earnings results on Friday, April 26th. The company reported $0.86 earnings per share for the quarter, topping the consensus estimate of $0.82 by $0.04. The business had revenue of $5.07 billion during the quarter, compared to the consensus estimate of $4.96 billion. Colgate-Palmolive had a net margin of 13.22% and a return on equity of 485.40%. The business’s quarterly revenue was up 6.2% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.73 earnings per share. Research analysts anticipate that Colgate-Palmolive will post 3.53 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be issued a $0.50 dividend. The ex-dividend date is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.12%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s payout ratio is presently 63.29%.

Wall Street Analyst Weigh In

A number of research firms recently weighed in on CL. Wells Fargo & Company upped their target price on shares of Colgate-Palmolive from $90.00 to $92.00 and gave the stock an “equal weight” rating in a research note on Monday, April 29th. Argus lifted their price objective on shares of Colgate-Palmolive from $97.00 to $107.00 and gave the stock a “buy” rating in a research report on Wednesday. StockNews.com downgraded shares of Colgate-Palmolive from a “strong-buy” rating to a “buy” rating in a research note on Tuesday, February 20th. UBS Group raised their price target on Colgate-Palmolive from $93.00 to $95.00 and gave the company a “buy” rating in a research note on Monday, January 29th. Finally, Stifel Nicolaus upped their price objective on Colgate-Palmolive from $94.00 to $95.00 and gave the stock a “buy” rating in a research report on Monday, April 29th. Three analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Colgate-Palmolive currently has an average rating of “Moderate Buy” and a consensus target price of $92.35.

Read Our Latest Analysis on Colgate-Palmolive

Insider Transactions at Colgate-Palmolive

In other news, insider Sally Massey sold 12,226 shares of the firm’s stock in a transaction on Thursday, May 9th. The shares were sold at an average price of $94.06, for a total value of $1,149,977.56. Following the completion of the sale, the insider now owns 13,924 shares in the company, valued at approximately $1,309,691.44. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. In other news, insider Sally Massey sold 12,226 shares of the stock in a transaction that occurred on Thursday, May 9th. The stock was sold at an average price of $94.06, for a total transaction of $1,149,977.56. Following the completion of the transaction, the insider now directly owns 13,924 shares of the company’s stock, valued at approximately $1,309,691.44. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, insider Jennifer Daniels sold 5,790 shares of the firm’s stock in a transaction that occurred on Friday, February 16th. The shares were sold at an average price of $83.96, for a total value of $486,128.40. Following the completion of the sale, the insider now directly owns 63,236 shares of the company’s stock, valued at $5,309,294.56. The disclosure for this sale can be found here. Insiders sold 124,771 shares of company stock worth $10,656,188 over the last 90 days. 0.37% of the stock is currently owned by insiders.

Colgate-Palmolive Company Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

See Also

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.